134 related articles for article (PubMed ID: 17415108)
21. [Oncogenic role of papillomaviruses].
Maroto Vela MC
An R Acad Nac Med (Madr); 1991; 108(4):733-44. PubMed ID: 1668357
[No Abstract] [Full Text] [Related]
22. Ancillary p16(INK4a) adds no meaningful value to the performance of ER/PR/Vim/CEA panel in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray study.
Yao CC; Kok LF; Lee MY; Wang PH; Wu TS; Tyan YS; Cheng YW; Kung MF; Han CP
Arch Gynecol Obstet; 2009 Sep; 280(3):405-13. PubMed ID: 19153755
[TBL] [Abstract][Full Text] [Related]
23. Is p16(INK4a) protein expression in oral ST lesions a reliable precancerous marker?
Greer RO; Meyers A; Said SM; Shroyer KR
Int J Oral Maxillofac Surg; 2008 Sep; 37(9):840-6. PubMed ID: 18606525
[TBL] [Abstract][Full Text] [Related]
24. [Cervix dysplasia and cervix carcinoma].
Bol P
Ned Tijdschr Tandheelkd; 1998 Dec; 105(12):455-6. PubMed ID: 11928150
[No Abstract] [Full Text] [Related]
25. Re: Distinction of endocervical and endometrial adenocarcinomas: immunohistochemical p16 expression correlated with human papilloma virus (HPV) DNA detection.
McCluggage WG
Am J Surg Pathol; 2004 Jul; 28(7):974. PubMed ID: 15223971
[No Abstract] [Full Text] [Related]
26. [The role of the cytological screening, HPV-test and the colposcopy for early detection of the precancerous lesions of the uterine cervix].
Ivanov S
Akush Ginekol (Sofiia); 2007; 46(9):45-9. PubMed ID: 18646309
[TBL] [Abstract][Full Text] [Related]
27. [Precancerous changes in the cervix uteri].
Miljković S
Med Pregl; 1978; 31(11-12):509-10. PubMed ID: 739960
[No Abstract] [Full Text] [Related]
28. ASC, TBS, and the power of ALTS.
Stoler MH
Am J Clin Pathol; 2007 Apr; 127(4):489-91. PubMed ID: 17369124
[No Abstract] [Full Text] [Related]
29. From Papanicolaou to papillomaviruses: evolving challenges in cervical cancer screening in the era of human papillomavirus vaccination.
Safaeian M; Sherman ME
J Natl Cancer Inst; 2013 Oct; 105(20):1524-6. PubMed ID: 24096622
[No Abstract] [Full Text] [Related]
30. p16INK4A positivity in benign, premalignant and malignant cervical glandular lesions: a potential diagnostic problem.
Murphy N; Heffron CC; King B; Ganuguapati UG; Ring M; McGuinness E; Sheils O; O'Leary JJ
Virchows Arch; 2004 Dec; 445(6):610-5. PubMed ID: 15378361
[TBL] [Abstract][Full Text] [Related]
31. Expression of p53 and coexistence of HPV in premalignant lesions and in cervical cancer.
Markowska J; Nowak M; Bar M; Harlozinska A
Eur J Gynaecol Oncol; 1995; 16(5):368-72. PubMed ID: 8549602
[TBL] [Abstract][Full Text] [Related]
32. [Application of DNA quantitative cytology in cervical cancer screening].
Zhong PP; Gu YQ; Wang J; Zhou QL; Wang AC; Sun XF
Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):469-70. PubMed ID: 24246868
[No Abstract] [Full Text] [Related]
33. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
[TBL] [Abstract][Full Text] [Related]
34. Comment on "New paradigm for prevention of cervical cancer" [Eur J Obstet Gynecol Reprod Biol 2007;130(1):25-9].
Mahajan NN; Gaikwad NL; Soni RN; Mahajan KN
Eur J Obstet Gynecol Reprod Biol; 2007 Nov; 135(1):140-1; author reply 141. PubMed ID: 17524549
[No Abstract] [Full Text] [Related]
35. [The detection of p16 protein in uterine cervix lesions].
Rotterová P; Nenutil R; Rotter L; Hanzelková Z; Dvoráková Z; Chovanec JZ; Kyclová J; Kren L
Ceska Gynekol; 2005 Jul; 70(4):295-8. PubMed ID: 16128131
[TBL] [Abstract][Full Text] [Related]
36. [Importance and value of colposcopic findings in decentralized hospitals in the case of patients with blood loss from the external genitalia].
Malanetto C; Zagami L; Spinelli V
Minerva Ginecol; 1978 May; 30(5):366-79. PubMed ID: 673233
[No Abstract] [Full Text] [Related]
37. Precancerous lesions and their clinical consequences.
Grundmann E
Arch Geschwulstforsch; 1980; 50(6):539-48. PubMed ID: 7224809
[No Abstract] [Full Text] [Related]
38. Human papillomavirus E6/E7 mRNA testing as a predictive marker for cervical carcinoma.
Lie AK; Kristensen G
Expert Rev Mol Diagn; 2008 Jul; 8(4):405-15. PubMed ID: 18598223
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of single and multiple human papillomavirus types in cervical cancer and precursor lesions in Hubei, China.
Cai HB; Ding XH; Chen CC
Oncology; 2009; 76(3):157-61. PubMed ID: 19174613
[TBL] [Abstract][Full Text] [Related]
40. [Classification, diagnosis and therapeutic approach in so-called precancerous conditions of the uterine cervix].
Zavadil M; Jirásek A; Motlík K; Rob L; Bauer J; Güttner V
Cesk Gynekol; 1987 Nov; 52(9):689-701. PubMed ID: 3447727
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
